Healthcare Services company Krsnaa Diagnostics announced Q1FY25 results:
Financial Highlights:
- Revenue from Operations: Rs 1,702 million in Q1FY25, a 22% increase compared to Rs 1,396 million in Q1FY24 and a 2% increase from Rs 1,663 million in Q4FY24.
- Other Income: Rs 73 million in Q1FY25, showing a 43% increase compared to Rs 42 million in Q1FY24.
- Total Income: Rs 1,775 million in Q1FY25, a 23% increase from Rs 1,438 million in Q1FY24 and a 4% increase from Rs 1,706 million in Q4FY24.
- EBITDA: Rs 442 million in Q1FY25, a 39% increase from Rs 319 million in Q1FY24, and virtually unchanged from Rs 445 million in Q4FY24.
- EBITDA Margin: 26% in Q1FY25, up from 23% in Q1FY24 but down from 27% in Q4FY24.
- EBIT: Rs 285 million in Q1FY25, a 44% increase compared to Rs 199 million in Q1FY24, and a 4% decrease from Rs 299 million in Q4FY24.
- EBIT Margin: 16% in Q1FY25, improved from 14% in Q1FY24 but down from 18% in Q4FY24.
- Profit After Tax (PAT): Rs 179 million in Q1FY25, representing a 24% increase from Rs 146 million in Q1FY24 and a 4% decrease from Rs 187 million in Q4FY24.
- PAT Margin: 11% in Q1FY25, consistent with the margin in Q1FY24 and Q4FY24.
- Reported Diluted EPS: Rs 5.46 in Q1FY25, compared to Rs 4.52 in Q1FY24 and Rs 5.70 in Q4FY24.
Operational Highlights:
- Krsnaa has bagged the contract for Tele-Radiology from BARC
- Krsnaa has signed an agreement for 5 MRIs to be installed in 5 districts of Madhya Pradesh
- Krsnaa has Launched Krsnaa Retail Pvt. Ltd to focus on increasing their retail presence beginning with 5 states i.e. Maharashtra, Punjab, Odisha, Assam & Himachal Pradesh.
- Krsnaa expanded its presence by establishing 395 new centers across the nation.
Commenting on the results, Yash Mutha, Joint Managing Director, said: “Krsnaa's exceptional service offerings, characterized by competitive pricing, have played a pivotal role in driving patient and test counts.
We are committed to enhancing the customer experience by offering exceptional healthcare solutions customized to individual needs. Krsnaa has established itself as a prominent player in the PPP sector and is one of the largest in the industry. Given the industry's growth and the next phase for our organization, we believe it is the right time to venture into the retail space. Our strategy is to offer a wide range of services to the general population, starting with states where we already have wellestablished lab and radiology centers through our PPP contracts. This approach will help us increase our margins and shorten our working capital cycle.
During the initial quarter of FY2025, Krsnaa accomplished a notable 22% increase compared to the previous year, leading to revenues totalling Rs. 1,702 million. Our EBIDTA reached Rs. 442 million with a 26% margin, and the net profit was Rs. 179 million with an 11% margin. This progress can be credited to our status as the government's preferred partner, heightened recognition of Krsnaa as a brand, maintaining high-quality services, and the successful and punctual execution of our projects.
We are also working on various other PAN India tenders, which will be announced once there is more clarity from the respective departments. At the gateway of boundless potential, we are unwavering in our commitment to adjust, create, and thrive. We have developed ambitious strategies to discover chances for progress and development, guaranteeing that we persist in positively influencing lives and contributing to the advancement of the healthcare sector.”
Commenting on the Business, Pallavi Bhatevara, Executive Director said: “Our company is well positioned to take advantage of the changes in the diagnostic industry, especially with the government's emphasis on delivering high-quality healthcare to all citizens. The budget for the National Health Mission (NHM) for 2024-25 is set at Rs 38,183 crores, marking a significant rise from the revised allocation of Rs 33,886 crores in 2023-24.
Krsnaa diagnostics limited continues to play a major role in providing high-quality and affordable diagnostic services. The provision of high-quality and affordable diagnostic services stands as a fundamental pillar within the healthcare industry. It is with great pleasure that I announce our successful execution of an agreement for the Madhya Pradesh Radiology tender, a significant opportunity that encompasses 5 MRI centre, along with these we have also bagged a contract for Tele-radiology from BARC. These showcase our capabilities and strength to grow in diagnostic industry.
Currently, Krsnaa Diagnostics is well-equipped to deploy 28 CT scan machines, 24 MRI machines, establish 153 labs, and set up 2,291 collection centers, all under various contractual agreements. The recent contract wins highlight the exceptional capabilities of our in-house teams. It reflects their proficiency in navigating the intricate bidding process, meeting all necessary requirements, and ultimately securing these contracts. As we begin these projects, Krsnaa Diagnostics is actively expanding its presence into new geographical regions, laying a strong foundation for sustainable, long-term growth.”